OM
OMRX.US Orthometrix Inc
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Mar 2015.
Is OMRX.US undervalued?
Graham numberThe Graham number of Orthometrix Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Orthometrix Inc fundamental analysis
No fundamental analysis for Orthometrix Inc yet.
Orthometrix Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Orthometrix Inc
Orthometrix, Inc. operates as a health care company, develops, sells, markets, and services musculoskeletal products used in sports medicine, rehabilitative medicine, and pain management. It also sells lithotripters used in urology to treat kidney stones. The company was formerly known as Norland Medical Systems, Inc. and changed its name to Orthometrix, Inc. in April 2002. Orthometrix, Inc. was incorporated in 1993 and is based in Naples, Florida.
Full company profileOrthometrix Inc financial statements
2015 annualized: Fiscal year 2015 is not finished. Income statement and cash flow are annualized from 4 quarters up to Mar 31, 2015, the balance sheet is the latest quarter. Figures change when the annual report is published.
Orthometrix Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2011 | 2012 | 2013 | 2015 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 9.19M | 902K | 1.57M | 1.18M | 1.51M | 2.36M | 2.41M | 1.58M | 651K | 1.07M | 904K |
| Gross Profit | 4.06M | 575K | 1.07M | 651K | 901K | 1.50M | 1.07M | 1.09M | 402K | 744K | 583K |
| Operating Income | - | - | - | -1.66M | -2.34M | -1.64M | -416K | 558K | -144K | 134K | -261K |
| Net Income | - | 3.26M | - | -1.94M | -2.39M | -1.98M | -1.08M | 434K | -231K | 63.5K | -123K |
| Balance Sheet | |||||||||||
| Total Assets | 2.36M | 1.48M | 754K | 407K | 531K | 1.17M | 794K | - | 214K | 296K | 507K |
| Total Liabilities | 5.10M | 971K | 1.54M | 1.25M | 1.33M | 3.46M | 3.66M | - | 3.16M | 3.18M | 3.20M |
| Shareholders' Equity | -2.74M | 507K | -785K | -838K | -799K | -2.29M | -2.87M | - | -2.95M | -2.89M | -2.69M |
| Cash & Short-term Investments | 16.0K | 26.0K | 44.0K | 150K | 22.9K | 4.01K | 27.1K | - | 64.3K | 14.5K | 50.1K |
| Cash Flow | |||||||||||
| Operating Cash Flow | - | - | - | -1.12M | -1.88M | -1.19M | -200K | 711K | 181K | 233K | 288K |
| Capital Expenditure | 7.00K | 0.00 | 16.0K | 3.20K | 30.6K | 7.65K | 9.11K | 0.00 | 0.00 | 0.00 | 3.00K |
| Ratios | |||||||||||
| ROE | - | 643.4% | - | - | - | - | - | - | - | - | - |
| ROA | - | 220.7% | - | -477.2% | -450.0% | -168.7% | -135.5% | - | -107.8% | 21.5% | -24.2% |
| Net Profit Margin | - | 361.6% | - | -164.8% | -157.7% | -83.8% | -44.7% | 27.5% | -35.4% | 5.9% | -13.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Orthometrix Inc dividends
Orthometrix Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 3:2 on Jun 17, 1996.
Who owns Orthometrix Inc
Ownership data of Orthometrix Inc is not available yet.
Orthometrix Inc company profile
- Company name
- Orthometrix Inc
- Ticker
- OMRX.US
- Exchange
- USA Stocks
- Listed since
- Aug 2, 1995
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 7
- Fiscal year end
- December
- Address
- 5621 Strand Boulevard, Naples, FL, United States, 34110
- Phone
- 914-694-5946
- Website
- -
About Orthometrix Inc
Orthometrix, Inc. operates as a health care company, develops, sells, markets, and services musculoskeletal products used in sports medicine, rehabilitative medicine, and pain management. It also sells lithotripters used in urology to treat kidney stones. The company was formerly known as Norland Medical Systems, Inc. and changed its name to Orthometrix, Inc. in April 2002. Orthometrix, Inc. was incorporated in 1993 and is based in Naples, Florida.
Orthometrix Inc management
2- Mr. Reynald G. Bonmati M.Sc. Ch.E., MBAFounder, Chief Executive Officer, President, Treasurer and Chairman of the Board · born 1948
- Mr. Arik Avni B.Sc., M.Sc., PTChief Technical Officer · born 1960